{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:31:06Z","timestamp":1790361066789,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Symbiosis International"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-05982-8","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:45:48Z","timestamp":1745941548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ruchika","family":"Kaul-Ghanekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi S.","family":"Kharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Walekar-Ghaisas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"1","key":"5982_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1875-595x.2012.00131.x","volume":"63","author":"B Gupta","year":"2013","unstructured":"Gupta B, Ariyawardana A, Johnson NW. Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J. 2013;63(1):12\u201325. https:\/\/doi.org\/10.1111\/j.1875-595x.2012.00131.x","journal-title":"Int Dent J"},{"key":"5982_CR2","unstructured":"Global Cancer Observatory. France: World Health Organization (WHO). 2022. Available from: https:\/\/gco.iarc.fr\/en"},{"issue":"10","key":"5982_CR3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S1470-2045(18)30447-9","volume":"19","author":"India State-Level Disease Burden Initiative Cancer C","year":"2018","unstructured":"India State-Level Disease Burden Initiative Cancer C. The burden of cancers and their variations across the States of India: the global burden of disease study 1990\u20132016. Lancet Oncol. 2018;19(10):1289\u2013306. PubMed PMID: 30219626; PubMed Central PMCID: PMCPMC6167407.","journal-title":"Lancet Oncol"},{"issue":"12","key":"5982_CR4","doi-asserted-by":"publisher","first-page":"13811","DOI":"10.1002\/cam4.6025","volume":"12","author":"R Sun","year":"2023","unstructured":"Sun R, Dou W, Liu W, et al. Global, regional, and national burden of oral cancer and its attributable risk factors from 1990 to 2019. Cancer Med. 2023;12(12):13811\u201320. https:\/\/doi.org\/10.1002\/cam4.6025. PubMed PMID: 37132165; PubMed Central PMCID: PMCPMC10315711.","journal-title":"Cancer Med"},{"key":"5982_CR5","doi-asserted-by":"publisher","unstructured":"Sathishkumar K, Chaturvedi M, Das P, et al. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian J Med Res. 2022;156(45):598\u2013607. https:\/\/doi.org\/10.4103\/ijmr.ijmr_1821_22. PubMed PMID: 36510887; PubMed Central PMCID: PMCPMC10231735.","DOI":"10.4103\/ijmr.ijmr_1821_22"},{"issue":"1","key":"5982_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41368-023-00249-w","volume":"15","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wang Z, Xu M, et al. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023;15(1):44. https:\/\/doi.org\/10.1038\/s41368-023-00249-w. PubMed PMID: 37736748; PubMed Central PMCID: PMCPMC10517027.","journal-title":"Int J Oral Sci"},{"key":"5982_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.12659\/PJR.900892","volume":"82","author":"P Palasz","year":"2017","unstructured":"Palasz P, Adamski L, Gorska-Chrzastek M, et al. Contemporary diagnostic imaging of oral squamous cell carcinoma - a review of literature. Pol J Radiol. 2017;82:193\u2013202. https:\/\/doi.org\/10.12659\/PJR.900892. PubMed PMID: 28439324; PubMed Central PMCID: PMCPMC5391802.","journal-title":"Pol J Radiol"},{"issue":"21","key":"5982_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMsr2210097","volume":"387","author":"V Bouvard","year":"2022","unstructured":"Bouvard V, Nethan ST, Singh D, et al. IARC perspective on oral cancer prevention. N Engl J Med. 2022;387(21):1999\u20132005. https:\/\/doi.org\/10.1056\/NEJMsr2210097","journal-title":"N Engl J Med"},{"issue":"1","key":"5982_CR9","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41467-024-45074-9","volume":"15","author":"GF Gil","year":"2024","unstructured":"Gil GF, Anderson JA, Aravkin A, et al. Health effects associated with chewing tobacco: a burden of proof study. Nat Commun. 2024;15(1):1082. https:\/\/doi.org\/10.1038\/s41467-024-45074-9. PubMed PMID: 38316758; PubMed Central PMCID: PMCPMC10844244.","journal-title":"Nat Commun"},{"key":"5982_CR10","unstructured":"WHO global report on trends in prevalence of tobacco use 2000-2025. 2021, World Health Organization: Geneva"},{"key":"5982_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00458-3","author":"H Rumgay","year":"2024","unstructured":"Rumgay H, Nethan ST, Shah R, et al. Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 2024. https:\/\/doi.org\/10.1016\/S1470-2045(24)00458-3","journal-title":"Lancet Oncol"},{"key":"5982_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(21)00065-7","author":"GBDCT Collaborators","year":"2021","unstructured":"Collaborators GBDCT. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Public Health. 2021;6(7):e482\u201399. https:\/\/doi.org\/10.1016\/S2468-2667(21)00065-7. PubMed PMID: 34051920; PubMed Central PMCID: PMCPMC8251505."},{"key":"5982_CR13","unstructured":"ICMR, ICMR-NCDIR. National Noncommunicable Disease Monitoring Survey (NNMS) 2017\u201318, Bengaluru, India. 2020."},{"issue":"9","key":"5982_CR14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ntr\/nty074","volume":"21","author":"S Asthana","year":"2019","unstructured":"Asthana S, Labani S, Kailash U, et al. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine Tob Res. 2019;21(9):1162\u201371. https:\/\/doi.org\/10.1093\/ntr\/nty074. PubMed PMID: 29790998.","journal-title":"Nicotine Tob Res"},{"key":"5982_CR15","doi-asserted-by":"publisher","unstructured":"Chaturvedi P, Singh A, Chien CY et al. Tobacco related oral cancer. BMJ. 2019;365:l2142. https:\/\/doi.org\/10.1136\/bmj.l2142. PubMed PMID: 31167798.","DOI":"10.1136\/bmj.l2142"},{"key":"5982_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-031-36797-7_32","volume-title":"Oral Medicine - A clinical guide","author":"R Alford","year":"2023","unstructured":"Alford R, Kujan O. Oral potentially malignant disorders. In: Balasubramaniam R, Yeoh S-C, Yap T, et al. editors. Oral Medicine - A clinical guide. Cham: Springer International Publishing; 2023. pp. 141\u20134."},{"key":"5982_CR17","doi-asserted-by":"publisher","unstructured":"Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.104550. PubMed PMID: 31981993.","DOI":"10.1016\/j.oraloncology.2019.104550"},{"key":"5982_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.oraloncology.2019.07.013","volume":"96","author":"T Yap","year":"2019","unstructured":"Yap T, Seers C, Koo K, et al. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders. Oral Oncol. 2019;96:113\u201320. PubMed PMID: 31422202.","journal-title":"Oral Oncol"},{"issue":"3","key":"5982_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ijc.28754","volume":"136","author":"KR Dionne","year":"2015","unstructured":"Dionne KR, Warnakulasuriya S, Zain RB, et al. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136(3):503\u201315. https:\/\/doi.org\/10.1002\/ijc.28754. PubMed PMID: 24482244.","journal-title":"Int J Cancer"},{"key":"5982_CR20","doi-asserted-by":"publisher","unstructured":"Tarakji B. Dentists\u2019 perception of oral potentially malignant disorders. Int Dent J. 2022;72(3):414\u2013419. https:\/\/doi.org\/10.1016\/j.identj.2022.01.004. PubMed PMID: 35227496; PubMed Central PMCID: PMCPMC9275301.","DOI":"10.1016\/j.identj.2022.01.004"},{"key":"5982_CR21","doi-asserted-by":"publisher","unstructured":"Warnakulasuriya S, Kujan O, Aguirre-Urizar JM et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating centre for oral cancer. 2021;27(8):1862\u201380. https:\/\/doi.org\/10.1111\/odi.13704","DOI":"10.1111\/odi.13704"},{"issue":"4","key":"5982_CR22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/1097-0142(197510)36:4<1386::aid-cncr2820360430>3.0.co;2-7","volume":"36","author":"CA Waldron","year":"1975","unstructured":"Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study 3256 oral leukoplakias. Cancer. 1975;36(4):1386\u201392. https:\/\/doi.org\/10.1002\/1097-0142(197510)36:4%3C1386::aid-cncr2820360430%3E3.0.co;2-7. PubMed PMID: 1175136; eng.","journal-title":"Cancer"},{"issue":"10","key":"5982_CR23","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","volume":"36","author":"S Warnakulasuriya","year":"2007","unstructured":"Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575\u201380. https:\/\/doi.org\/10.1111\/j.1600-0714.2007.00582.x. PubMed PMID: 17944749.","journal-title":"J Oral Pathol Med"},{"key":"5982_CR24","doi-asserted-by":"publisher","unstructured":"Su YF, Chen YJ, Tsai FT, et al. Current insights into oral cancer diagnostics. Diagnostics (Basel). 2021;11(7). https:\/\/doi.org\/10.3390\/diagnostics11071287. PubMed PMID: 34359370; PubMed Central PMCID: PMCPMC8303371.","DOI":"10.3390\/diagnostics11071287"},{"key":"5982_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1596\/978-1-4648-0349-9_ch5","volume-title":"Cancer","author":"R Sankaranarayanan","year":"2015","unstructured":"Rengaswamy Sankaranarayanan KR, Hemantha Amarasinghe S, Subramanian, Johnson N. Oral cancer: prevention, early detection, and treatment. Vol. 3. International Bank for Reconstruction and Development \/ The World Bank. (Jamison DT, Nugent R, Gelband H editors DISEASE CONTROL PRIORITIES). https:\/\/doi.org\/10.1596\/978-1-4648-0349-9_ch5","edition":"3"},{"issue":"4","key":"5982_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12105-023-01600-7","volume":"17","author":"A Garg","year":"2023","unstructured":"Garg A, Urs AB, Koner BC, et al. Evaluation of diagnostic significance of salivary miRNA-184 and miRNA-21 in oral squamous cell carcinoma and oral potentially malignant disorders. Head Neck Pathol. 2023;17(4):961\u20138. https:\/\/doi.org\/10.1007\/s12105-023-01600-7. PubMed PMID: 38015343; PubMed Central PMCID: PMCPMC10739647. eng.","journal-title":"Head Neck Pathol"},{"issue":"2","key":"5982_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jds.2021.09.020","volume":"17","author":"HF Tu","year":"2022","unstructured":"Tu HF, Lin LH, Chang KW, et al. Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder. J Dent Sci. 2022;17(2):659\u201365. https:\/\/doi.org\/10.1016\/j.jds.2021.09.020. PubMed PMID: 35756782; PubMed Central PMCID: PMCPMC9201538. eng.","journal-title":"J Dent Sci"},{"issue":"6","key":"5982_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.7150\/jca.92489","volume":"15","author":"J Zheng","year":"2024","unstructured":"Zheng J, Chen K, Cai L, et al. A potential biomarker for the early diagnosis of OSCC: saliva and serum PrP(C). J Cancer. 2024;15(6):1593\u2013602. https:\/\/doi.org\/10.7150\/jca.92489. PubMed PMID: 38370370; PubMed Central PMCID: PMCPMC10869989. eng.","journal-title":"J Cancer"},{"issue":"1","key":"5982_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12885-021-07932-3","volume":"21","author":"MMA Chiamulera","year":"2021","unstructured":"Chiamulera MMA, Zancan CB, Remor AP, et al. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):205. https:\/\/doi.org\/10.1186\/s12885-021-07932-3. PubMed PMID: 33639868; PubMed Central PMCID: PMCPMC7912500.","journal-title":"BMC Cancer"},{"key":"5982_CR30","doi-asserted-by":"publisher","unstructured":"Chibly AM, Aure MH, Patel VN, Hoffman MP. Salivary gland function, development, and regeneration. 2022. 102(3):1495\u2013552. https:\/\/doi.org\/10.1152\/physrev.00015.2021.","DOI":"10.1152\/physrev.00015.2021"},{"key":"5982_CR31","doi-asserted-by":"publisher","unstructured":"Neves CR, Buskermolen J, Roffel S, Waaijman T, Thon M, Veerman E, et al. Human saliva stimulates skin and oral wound healing in vitro. 2019;13(6):1079\u201392. https:\/\/doi.org\/10.1002\/term.2865.","DOI":"10.1002\/term.2865"},{"key":"5982_CR32","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z","volume":"89","author":"JB Epstein","year":"2000","unstructured":"Epstein JB, Gorsky M, Guglietta A, et al. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancers. 2000;89:2258\u201365.","journal-title":"Cancers"},{"key":"5982_CR33","doi-asserted-by":"crossref","unstructured":"Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing \u2014 past, present and future perspectives. The Surgeon. 2008;6(3):172\u20137.","DOI":"10.1016\/S1479-666X(08)80114-X"},{"key":"5982_CR34","doi-asserted-by":"crossref","unstructured":"Sarosiek J, Bilski J, Murty VLN, Slomiany A, Slomiany BL. Role of salivary epidermal growth factor in the maintenance of physicochemical characteristics of oral and gastric mucosal mucus coat. Biochemical and Biophysical Research Communications. 1988;152(3):1421\u20137. https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0006291X88804443?via%3Dihub.","DOI":"10.1016\/S0006-291X(88)80444-3"},{"issue":"1","key":"5982_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","volume":"8","author":"Q Li","year":"2023","unstructured":"Li Q, Tie Y, Alu A, et al. Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal Transduct Target Ther. 2023;8(1):31. https:\/\/doi.org\/10.1038\/s41392-022-01297-0. PubMed PMID: 36646686; PubMed Central PMCID: PMCPMC9842704.","journal-title":"Signal Transduct Target Ther"},{"key":"5982_CR36","doi-asserted-by":"publisher","first-page":"104552","DOI":"10.1016\/j.oraloncology.2019.104552","volume":"102","author":"PJ Hsu","year":"2020","unstructured":"Hsu PJ, Yan K, Shi H, et al. Molecular biology of oral cavity squamous cell carcinoma. Oral Oncol. 2020;102:104552. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.104552. PubMed PMID: 31918173; PubMed Central PMCID: PMCPMC7659372.","journal-title":"Oral Oncol"},{"issue":"2","key":"5982_CR37","first-page":"72","volume":"13","author":"D Adorno-Farias","year":"2022","unstructured":"Adorno-Farias D, Badilla SM, Vidal GP, et al. Epidermal growth factor receptor (EGFR) is overexpressed in both dysplasia and neoplastic oral disease. Oral Maxillofacial Pathol J. 2022;13(2):72\u20138.","journal-title":"Oral Maxillofacial Pathol J"},{"issue":"11","key":"5982_CR38","doi-asserted-by":"publisher","first-page":"E408","DOI":"10.1002\/lary.26797","volume":"127","author":"L Zanotti","year":"2017","unstructured":"Zanotti L, Paderno A, Piazza C, et al. Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer. Laryngoscope. 2017;127(11):E408\u201314. https:\/\/doi.org\/10.1002\/lary.26797. PubMed PMID: 28782189.","journal-title":"Laryngoscope"},{"issue":"6","key":"5982_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/PAI.0b013e3182143367","volume":"19","author":"FO Bernardes VFt, Gleber-Netto","year":"2011","unstructured":"Bernardes VFt, Gleber-Netto FO, Sousa SF, et al. EGF in saliva and tumor samples of oral squamous cell carcinoma. Appl Immunohistochem Mol Morphology. 2011;19(6):528\u201333. https:\/\/doi.org\/10.1097\/PAI.0b013e3182143367","journal-title":"Appl Immunohistochem Mol Morphology"},{"issue":"40","key":"5982_CR40","first-page":"1","volume":"29","author":"F Vanessa","year":"2010","unstructured":"Vanessa F, Bernardes FOG-N, S\u00edlvia F, Sousa Tarc\u00edliaA, Silva, Maria C\u00e1ssia F Aguiar. Clinical significance of EGFR, Her-2, and EGF in oral squamous cell carcinoma-a case-control study. J Experimental Clin Cancer Res. 2010;29(40):1\u20137.","journal-title":"J Experimental Clin Cancer Res"},{"key":"5982_CR41","doi-asserted-by":"publisher","unstructured":"Civico-Ortega JL, Gonzalez-Ruiz I, Ramos-Garcia P, et al. Prognostic and clinicopathological significance of epidermal growth factor receptor (EGFR) expression in oral squamous cell carcinoma: systematic review and meta-analysis. Int J Mol Sci. 2023;24(15). https:\/\/doi.org\/10.3390\/ijms241511888. PubMed PMID: 37569265; PubMed Central PMCID: PMCPMC10419199.","DOI":"10.3390\/ijms241511888"},{"issue":"1","key":"5982_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.oraloncology.2004.06.004","volume":"41","author":"R Balicki","year":"2005","unstructured":"Balicki R, Grabowska SZ, Citko A. Salivary epidermal growth factor in oral cavity cancer. Oral Oncol. 2005;41(1):48\u201355. https:\/\/doi.org\/10.1016\/j.oraloncology.2004.06.004","journal-title":"Oral Oncol"},{"key":"5982_CR43","doi-asserted-by":"publisher","unstructured":"Moorthy A, Venugopal DC, Shyamsundar V, et al. Identification of EGFR as a biomarker in saliva and buccal cells from oral submucous fibrosis patients-A baseline study. Diagnostics (Basel). 2022;12(8). https:\/\/doi.org\/10.3390\/diagnostics12081935. PubMed PMID: 36010285; PubMed Central PMCID: PMCPMC9406318.","DOI":"10.3390\/diagnostics12081935"},{"key":"5982_CR44","doi-asserted-by":"publisher","unstructured":"Tang Y, Zhu W, Chen K et al. New technologies in computer-aided drug design: toward target identification and new chemical entity discovery. Drug Discov Today Technol. 2006;3(3):307\u201313. https:\/\/doi.org\/10.1016\/j.ddtec.2006.09.004. PubMed PMID: 24980533; PubMed Central PMCID: PMCPMC7185835.","DOI":"10.1016\/j.ddtec.2006.09.004"},{"issue":"4","key":"5982_CR45","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149\u201360. https:\/\/doi.org\/10.3758\/BRM.41.4.1149","journal-title":"Behav Res Methods"},{"key":"5982_CR46","doi-asserted-by":"publisher","unstructured":"Faul F, Erdfelder E, Lang A-G et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391. https:\/\/doi.org\/10.3758\/BF03193146","DOI":"10.3758\/BF03193146"},{"issue":"3","key":"5982_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1601-0825.2000.tb00332.x","volume":"6","author":"SR Moore","year":"2000","unstructured":"Moore SR, Pierce AM, Wilson DF. Oral cancer\u2019--the terminology dilemma. Oral Dis. 2000;6(3):191\u20133. PubMed PMID: 10822364; eng.","journal-title":"Oral Dis"},{"issue":"3","key":"5982_CR48","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345. PubMed PMID: 3203132; eng.","journal-title":"Biometrics"},{"issue":"1","key":"5982_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C32::aid-cncr2820030106%3E3.0.co;2-3. PubMed PMID: 15405679; eng.","journal-title":"Cancer"},{"key":"5982_CR50","doi-asserted-by":"publisher","unstructured":"Hughes G. Youden\u2019s index and the weight of evidence revisited. Methods of information in medicine. 2015;54(6):576\u20137. https:\/\/doi.org\/10.3414\/me15-04-0007. PubMed PMID: 26548463; eng.","DOI":"10.3414\/me15-04-0007"},{"issue":"1","key":"5982_CR51","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6(1):92. https:\/\/doi.org\/10.1038\/s41572-020-00224-3. PubMed PMID: 33243986; PubMed Central PMCID: PMCPMC7944998.","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"5982_CR52","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.oraloncology.2005.12.014","volume":"42","author":"O Kujan","year":"2006","unstructured":"Kujan O, Oliver RJ, Khattab A, et al. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol. 2006;42(10):987\u201393. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.12.014. PubMed PMID: 16731030.","journal-title":"Oral Oncol"},{"issue":"1","key":"5982_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.oooo.2012.10.015","volume":"115","author":"P Nankivell","year":"2013","unstructured":"Nankivell P, Williams H, Matthews P, et al. The binary oral dysplasia grading system: validity testing and suggested improvement. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(1):87\u201394. https:\/\/doi.org\/10.1016\/j.oooo.2012.10.015. PubMed PMID: 23217539.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"7","key":"5982_CR54","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.oraloncology.2012.01.017","volume":"48","author":"R Mishra","year":"2012","unstructured":"Mishra R. Biomarkers of oral premalignant epithelial lesions for clinical application. Oral Oncol. 2012;48(7):578\u201384. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.01.017. PubMed PMID: 22342569.","journal-title":"Oral Oncol"},{"issue":"7","key":"5982_CR55","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/sj.bjc.6605290","volume":"101","author":"T Shpitzer","year":"2009","unstructured":"Shpitzer T, Hamzany Y, Bahar G, et al. Salivary analysis of oral cancer biomarkers. Br J Cancer. 2009;101(7):1194\u20138. https:\/\/doi.org\/10.1038\/sj.bjc.6605290. PubMed PMID: 19789535; PubMed Central PMCID: PMCPMC2768098.","journal-title":"Br J Cancer"},{"key":"5982_CR56","doi-asserted-by":"publisher","first-page":"103571","DOI":"10.1016\/j.jprot.2019.103571","volume":"211","author":"LM Chi","year":"2020","unstructured":"Chi LM, Hsiao YC, Chien KY, et al. Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry. J Proteom. 2020;211:103571. https:\/\/doi.org\/10.1016\/j.jprot.2019.103571. PubMed PMID: 31689561.","journal-title":"J Proteom"},{"issue":"1","key":"5982_CR57","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbcan.2006.06.001","volume":"1766","author":"S Sebastian","year":"2006","unstructured":"Sebastian S, Settleman J, Reshkin SJ, et al. The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta. 2006;1766(1):120\u201339. https:\/\/doi.org\/10.1016\/j.bbcan.2006.06.001. PubMed PMID: 16889899.","journal-title":"Biochim Biophys Acta"},{"key":"5982_CR58","doi-asserted-by":"publisher","unstructured":"Ding Y, Su J-z, Yu G-y. Comparison of epidermal growth factor expression and secretion in human salivary glands. Arch Oral Biol. 2024;164:105989. https:\/\/doi.org\/10.1016\/j.archoralbio.2024.105989","DOI":"10.1016\/j.archoralbio.2024.105989"},{"issue":"2","key":"5982_CR59","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yexcr.2018.06.036","volume":"370","author":"DJ Wisniewski","year":"2018","unstructured":"Wisniewski DJ, Ma T, Schneider A. Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation. Exp Cell Res. 2018;370(2):343\u201352. https:\/\/doi.org\/10.1016\/j.yexcr.2018.06.036. PubMed PMID: 29966661; PubMed Central PMCID: PMCPMC6108942.","journal-title":"Exp Cell Res"},{"key":"5982_CR60","doi-asserted-by":"publisher","first-page":"153287","DOI":"10.1016\/j.prp.2020.153287","volume":"218","author":"S Bhattacharyya","year":"2021","unstructured":"Bhattacharyya S, Ray S, Saha D, et al. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in oral leukoplakia- a cytochemistry based approach. Pathol Res Pract. 2021;218:153287. https:\/\/doi.org\/10.1016\/j.prp.2020.153287. PubMed PMID: 33454586.","journal-title":"Pathol Res Pract"},{"issue":"6","key":"5982_CR61","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.18632\/oncotarget.13771","volume":"8","author":"X Q","year":"2017","unstructured":"Q X, Q Z. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Oncotarget. 2017;8(6):9557\u201371. https:\/\/doi.org\/10.18632\/oncotarget.13771","journal-title":"Oncotarget"},{"issue":"2","key":"5982_CR62","doi-asserted-by":"publisher","first-page":"e55795","DOI":"10.1371\/journal.pone.0055795","volume":"8","author":"SC Ko","year":"2013","unstructured":"Ko SC, Huang CR, Shieh JM, et al. Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1beta expression. PLoS ONE. 2013;8(2):e55795. https:\/\/doi.org\/10.1371\/journal.pone.0055795. PubMed PMID: 23383347; PubMed Central PMCID: PMCPMC3562190.","journal-title":"PLoS ONE"},{"key":"5982_CR63","doi-asserted-by":"crossref","unstructured":"Epstein JB, Gorsky M, Guglietta A, et al. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancers. 2000;89:2258\u201365.","DOI":"10.1002\/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z"},{"issue":"8","key":"5982_CR64","first-page":"471","volume":"53","author":"F Agha-Hosseini","year":"2014","unstructured":"Agha-Hosseini F, Mohebbian M, Sarookani M-R, et al. Comparative evaluation of EGF in oral lichen planus and oral squamous cell carcinoma. Acta Medica Iranica. 2014;53(8):471\u20135.","journal-title":"Acta Medica Iranica"},{"issue":"4","key":"5982_CR65","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.oooo.2014.12.017","volume":"119","author":"F Jaeger","year":"2015","unstructured":"Jaeger F, Assuncao AC, Caldeira PC, et al. Is salivary epidermal growth factor a biomarker for oral leukoplakia? A preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(4):451\u20138. https:\/\/doi.org\/10.1016\/j.oooo.2014.12.017. PubMed PMID: 25701553.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"5","key":"5982_CR66","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3892\/ol.2014.1946","volume":"7","author":"Y Ohnishi","year":"2014","unstructured":"Ohnishi Y, Watanabe M, Yasui H, et al. Effects of epidermal growth factor on the invasive activity and cytoskeleton of oral squamous cell carcinoma cell lines. Oncol Lett. 2014;7(5):1439\u201342. PubMed PMID: 24765152; PubMed Central PMCID: PMCPMC3997698.","journal-title":"Oncol Lett"},{"issue":"6","key":"5982_CR67","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.18632\/oncotarget.13771","volume":"8","author":"QZQ Xu","year":"2017","unstructured":"Xu QZQ, Ishida Y, Hajjar S, Tang X, Shi H, Dang CV, Le AD. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Oncotarget. 2017;8(6):9557\u201371. https:\/\/doi.org\/10.18632\/oncotarget.13771","journal-title":"Oncotarget"},{"key":"5982_CR68","doi-asserted-by":"publisher","unstructured":"Bernardes VF, Gleber-Netto FO, Sousa SF, et al. EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study. BMJ Open. 2013;3(1). https:\/\/doi.org\/10.1136\/bmjopen-2012-002077. PubMed PMID: 23358562; PubMed Central PMCID: PMCPMC3563135.","DOI":"10.1136\/bmjopen-2012-002077"},{"issue":"7","key":"5982_CR69","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ijom.2018.01.002","volume":"47","author":"V Costa","year":"2018","unstructured":"Costa V, Kowalski LP, Coutinho-Camillo CM, et al. EGFR amplification and expression in oral squamous cell carcinoma in young adults. Int J Oral Maxillofac Surg. 2018;47(7):817\u201323. PubMed PMID: 29395668.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"5982_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/bs.acr.2020.04.003","volume":"147","author":"S Talukdar","year":"2020","unstructured":"Talukdar S, Emdad L, Das SK, et al. EGFR: an essential receptor tyrosine kinase-regulator of cancer stem cells. Adv Cancer Res. 2020;147:161\u201388. https:\/\/doi.org\/10.1016\/bs.acr.2020.04.003. PubMed PMID: 32593400.","journal-title":"Adv Cancer Res"},{"issue":"2","key":"5982_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.oraloncology.2006.02.009","volume":"43","author":"K Laimer","year":"2007","unstructured":"Laimer K, Spizzo G, Gastl G, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007;43(2):193\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2006.02.009. PubMed PMID: 16854613.","journal-title":"Oral Oncol"},{"issue":"16","key":"5982_CR72","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1200\/JCO.2006.06.6605","volume":"25","author":"S Temam","year":"2007","unstructured":"Temam S, Kawaguchi H, El-Naggar AK, et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol. 2007;25(16):2164\u201370. https:\/\/doi.org\/10.1200\/JCO.2006.06.6605. PubMed PMID: 17538160.","journal-title":"J Clin Oncol"},{"issue":"25","key":"5982_CR73","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","volume":"24","author":"CH Chung","year":"2006","unstructured":"Chung CH, Ely K, McGavran L, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006;24(25):4170\u20136. PubMed PMID: 16943533.","journal-title":"J Clin Oncol"},{"issue":"4","key":"5982_CR74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/sj.bjc.6601171","volume":"89","author":"IH Chen","year":"2003","unstructured":"Chen IH, Chang JT, Liao CT, et al. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer. 2003;89(4):681\u20136. https:\/\/doi.org\/10.1038\/sj.bjc.6601171. PubMed PMID: 12915878; PubMed Central PMCID: PMCPMC2376917.","journal-title":"Br J Cancer"},{"issue":"3","key":"5982_CR75","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/cam4.2772","volume":"9","author":"XX Lv","year":"2020","unstructured":"Lv XX, Zheng XY, Yu JJ, et al. EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2. Cancer Med. 2020;9(3):1131\u201340. https:\/\/doi.org\/10.1002\/cam4.2772. PubMed PMID: 31823521; PubMed Central PMCID: PMCPMC6997074.","journal-title":"Cancer Med"},{"issue":"2","key":"5982_CR76","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3892\/ol.2016.5500","volume":"13","author":"Y Ohnishi","year":"2017","unstructured":"Ohnishi Y, Yasui H, Kakudo K, et al. Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells. Oncol Lett. 2017;13(2):930\u20136. https:\/\/doi.org\/10.3892\/ol.2016.5500. PubMed PMID: 28356980; PubMed Central PMCID: PMCPMC5351309.","journal-title":"Oncol Lett"},{"issue":"4","key":"5982_CR77","first-page":"1547","volume":"34","author":"F ANDRESSA","year":"2014","unstructured":"Andressa F, Ribeiro P, Noguti J, et al. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer- a promising approach. Anticancer Res. 2014;34(4):1547\u201352.","journal-title":"Anticancer Res"},{"issue":"1","key":"5982_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41374-020-00486-1","volume":"101","author":"S Yoshimoto","year":"2021","unstructured":"Yoshimoto S, Morita H, Matsuda M, et al. NFAT5 promotes oral squamous cell carcinoma progression in a hyperosmotic environment. Lab Invest. 2021;101(1):38\u201350. https:\/\/doi.org\/10.1038\/s41374-020-00486-1. PubMed PMID: 32901097; PubMed Central PMCID: PMCPMC7758185.","journal-title":"Lab Invest"},{"key":"5982_CR79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.7150\/oncm.22614","volume":"3","author":"Y Mirza","year":"2018","unstructured":"Mirza Y, Ali SA, Awan M, Idress R, Naeem S, Zahid N, Qadeer U. Overexpression of EGFR in oral premalignant lesions and OSCC and its impact on survival and recurrence. Oncomedicine. 2018;3:28\u201336. https:\/\/doi.org\/10.7150\/oncm.22614","journal-title":"Oncomedicine"},{"key":"5982_CR80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3892\/ol.2015.3833","volume":"11","author":"Y KIMURA","year":"2016","unstructured":"KIMURA Y, KITAHARA H, OOI K, et al. Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition. Oncol Lett. 2016;11:201\u20137. https:\/\/doi.org\/10.3892\/ol.2015.3833","journal-title":"Oncol Lett"},{"issue":"6","key":"5982_CR81","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/1055-9965.EPI-15-0949","volume":"25","author":"T Bates","year":"2016","unstructured":"Bates T, Kennedy M, Diajil A, et al. Changes in epidermal growth factor receptor gene copy number during oral carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2016;25(6):927\u201335. https:\/\/doi.org\/10.1158\/1055-9965.EPI-15-0949. PubMed PMID: 27197272.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"5982_CR82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0300-483x(92)90153-6","volume":"75","author":"SL Wang","year":"1992","unstructured":"Wang 1 SL, Wu-Wang MMCY, Mardirossian G, Leung C, Slomiany A, Slomiany BL. Effect of cigarette smoking on salivary epidermal growth factor (EGF) and EGF receptor in human buccal mucosa. Toxicology. 1992;75(2):145\u201357. https:\/\/doi.org\/10.1016\/0300-483x(92)90153-6","journal-title":"Toxicology"},{"issue":"1","key":"5982_CR83","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/s0014-4827(02)00105-2","volume":"284","author":"RC Harris","year":"2003","unstructured":"Harris RC, Chung E, Coffey RJ. EGF receptor ligands. Exp Cell Res. 2003;284(1):2\u201313. https:\/\/doi.org\/10.1016\/s0014-4827(02)00105-2. PubMed PMID: 12648462.","journal-title":"Exp Cell Res"},{"issue":"1","key":"5982_CR84","doi-asserted-by":"publisher","first-page":"e54136","DOI":"10.1371\/journal.pone.0054136","volume":"8","author":"JM Sanders","year":"2013","unstructured":"Sanders JM, Wampole ME, Thakur ML, et al. Molecular determinants of epidermal growth factor binding: a molecular dynamics study. PLoS ONE. 2013;8(1):e54136. https:\/\/doi.org\/10.1371\/journal.pone.0054136. PubMed PMID: 23382875; PubMed Central PMCID: PMCPMC3554757.","journal-title":"PLoS ONE"},{"key":"5982_CR85","doi-asserted-by":"publisher","first-page":"8739473","DOI":"10.1155\/2018\/8739473","volume":"2018","author":"S Rayego-Mateos","year":"2018","unstructured":"Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, et al. Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage. Mediators Inflamm. 2018;2018:8739473. https:\/\/doi.org\/10.1155\/2018\/8739473. PubMed PMID: 30670929; PubMed Central PMCID: PMCPMC6323488.","journal-title":"Mediators Inflamm"},{"issue":"8","key":"5982_CR86","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1600-0854.2009.00943.x","volume":"10","author":"K Roepstorff","year":"2009","unstructured":"Roepstorff K, Grandal MV, Henriksen L, et al. Differential effects of EGFR ligands on endocytic sorting of the receptor. Traffic. 2009;10(8):1115\u201327. https:\/\/doi.org\/10.1111\/j.1600-0854.2009.00943.x. PubMed PMID: 19531065; PubMed Central PMCID: PMCPMC2723868.","journal-title":"Traffic"},{"key":"5982_CR87","doi-asserted-by":"publisher","unstructured":"Freed DM, Bessman NJ, Kiyatkin A et al. EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics. Cell. 2017;171(3):683\u2013695 e18. https:\/\/doi.org\/10.1016\/j.cell.2017.09.017. PubMed PMID: 28988771; PubMed Central PMCID: PMCPMC5650921.","DOI":"10.1016\/j.cell.2017.09.017"},{"issue":"8","key":"5982_CR88","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/14737159.2021.1944106","volume":"21","author":"NS Piyarathne","year":"2021","unstructured":"Piyarathne NS, Rasnayake R, Angammana R, et al. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - a systematic review. Expert Rev Mol Diagn. 2021;21(8):789\u2013807. PubMed PMID: 34148471.","journal-title":"Expert Rev Mol Diagn"},{"key":"5982_CR89","doi-asserted-by":"publisher","unstructured":"Bastias D, Maturana A, Marin C, et al. Salivary biomarkers for oral cancer detection: an exploratory systematic review. Int J Mol Sci. 2024;25(5). https:\/\/doi.org\/10.3390\/ijms25052634. PubMed PMID: 38473882; PubMed Central PMCID: PMCPMC10932009.","DOI":"10.3390\/ijms25052634"},{"issue":"36","key":"5982_CR90","doi-asserted-by":"publisher","first-page":"38866","DOI":"10.18632\/oncotarget.5640","volume":"6","author":"C-H Lee","year":"2015","unstructured":"Lee C-H, Syu S-H, Liu K-J, et al. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer. Oncotarget. 2015;6(36):38866\u201380. https:\/\/doi.org\/10.18632\/oncotarget.5640","journal-title":"Oncotarget"},{"issue":"12","key":"5982_CR91","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1158\/1541-7786.Mcr-13-0187","volume":"11","author":"EV Fletcher","year":"2013","unstructured":"Fletcher EV, Love-Homan L, Sobhakumari A, et al. EGFR inhibition induces proinflammatory cytokines via NOX4 in HNSCC. Mol cancer Research: MCR. 2013;11(12):1574\u201384. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-13-0187. PubMed PMID: 24048704; PubMed Central PMCID: PMCPMC3869882. eng.","journal-title":"Mol cancer Research: MCR"},{"issue":"1","key":"5982_CR92","doi-asserted-by":"publisher","first-page":"2432222","DOI":"10.1080\/20565623.2024.2432222","volume":"11","author":"D Ghalwash","year":"2025","unstructured":"Ghalwash D, Ammar A, Abou-Bakr A, et al. Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population. Future Sci OA. 2025;11(1):2432222. https:\/\/doi.org\/10.1080\/20565623.2024.2432222. PubMed PMID: 39641414; PubMed Central PMCID: PMCPMC11633404. eng.","journal-title":"Future Sci OA"},{"key":"5982_CR93","doi-asserted-by":"publisher","unstructured":"Elmahgoub F. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors? Evidence-Based dentistry. 2022;23(1):30\u20131. https:\/\/doi.org\/10.1038\/s41432-022-0249-8","DOI":"10.1038\/s41432-022-0249-8"},{"key":"5982_CR94","doi-asserted-by":"publisher","unstructured":"Ghalwash DM. Diagnostic and prognostic value of salivary biomarkers in oral cancer and precancer: review article. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2020 2020\/11\/01\/;32(6):538\u2013543. https:\/\/doi.org\/10.1016\/j.ajoms.2020.06.013","DOI":"10.1016\/j.ajoms.2020.06.013"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-05982-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:45:57Z","timestamp":1745941557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-05982-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5982"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-05982-8","relation":{"references":[{"id-type":"doi","id":"10.1016\/S2468-2667(21)00065-7","asserted-by":"subject"}]},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study is completed after approval from the Institutional Ethics Committee Bharati Vidyapeeth (Deemed to be University), Pune (Maharashtra), India, with IRB Number: IRB-1223\/DUHS\/Approval\/2019\/34. All procedures performed in studies involving human participants were under the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent in writing from all the research participants was obtained according to Helsinki\u2019s declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The current study does not contain any images or videos related to any research participant. The consent for publication is obtained from all research participants included in the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"663"}}